Selvendiran, Karuppaiyah <br/><br/>
NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts.  [electronic resource] 

 -  Cell cycle (Georgetown, Tex.)  Jan 2008 
 - 81-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1551-4005 
<br/><br/><label>Standard No.: </label>10.4161/cc.7.1.5103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aspirin--analogs & derivatives<br/>Cell Line, Tumor<br/>Cisplatin--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm--drug effects<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Ovarian Neoplasms--drug therapy<br/>Proto-Oncogene Proteins c-bcl-2--biosynthesis<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Transplantation, Heterologous--pathology